| Reference : In vivo evaluation of antithrombotic potency of BM-613, a thromboxane A2 receptor antago... |
| Scientific congresses and symposiums : Unpublished conference | |||
| Human health sciences : Pharmacy, pharmacology & toxicology | |||
| http://hdl.handle.net/2268/68536 | |||
| In vivo evaluation of antithrombotic potency of BM-613, a thromboxane A2 receptor antagonist, in a rat model of arterial thrombosis | |
| English | |
Hanson, Julien [Université de Liège - ULg > Département de pharmacie > Chimie pharmaceutique >] | |
| Rolin, S. [> >] | |
| De Leval, Xavier [> >] | |
| Reynaud, D. [> >] | |
| Qiao, N. [> >] | |
| Neven, Ph. [> >] | |
| Masereel, B. [> >] | |
| Pace-Asciak, Cecil R. [> >] | |
Pirotte, Bernard [Université de Liège - ULg > Département de pharmacie > Chimie pharmaceutique >] | |
| Dogné, Jean-Michel [Université de Liège - ULg > Département de pharmacie > Département de pharmacie >] | |
| May-2004 | |
| Yes | |
| International | |
| 12th Forum of Pharmaceutical Sciences | |
| 6-7 mai 2004 | |
| Blankenberge | |
| Belgique | |
| http://hdl.handle.net/2268/68536 |
There is no file associated with this reference.
All documents in ORBi are protected by a user license.